Enimmune corporation - Laporan Laba Rugi (TTM)

Enimmune corporation
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Enimmune corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 12 23 48 73 91 110 131 151 170 188 149 109 76 43 47 51 45 40 41 42
Change (%) 90.02 109.80 52.34 25.10 20.07 18.84 15.85 12.30 10.96 -20.99 -26.56 -30.11 -43.08 8.42 7.77 -10.73 -12.02 2.90 2.82
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 8 15 29 43 57 71 101 131 149 168 130 92 79 67 66 66 46 26 27 28
Change (%) 90.08 97.35 49.33 32.30 24.41 42.26 29.71 13.86 12.18 -22.56 -29.14 -13.64 -15.80 -0.78 -0.79 -30.49 -43.85 4.61 4.41
% of Revenue 64.05 64.07 60.27 59.08 62.48 64.74 77.50 86.77 87.97 88.94 87.17 84.11 103.93 153.74 140.69 129.51 100.85 64.36 65.43 66.44
Gross Operating Profit 4 8 19 30 34 39 29 20 20 21 19 17 -3 -23 -19 -15 -0 14 14 14
Change (%) 89.90 132.01 56.90 14.72 12.83 -24.16 -31.86 2.08 2.04 -8.34 -9.09 -117.29 678.32 -17.91 -21.82 -97.42 -3,780.72 -0.18 -0.18
% of Revenue 35.95 35.93 39.73 40.92 37.52 35.26 22.50 13.23 12.03 11.06 12.83 15.89 -3.93 -53.74 -40.69 -29.51 -0.85 35.64 34.57 33.56
SG&A 28 32 35 39 41 43 45 47 54 60 64 68 75 81 84 88 84 80 80 80
Change (%) 14.80 10.36 9.39 5.04 4.80 5.35 5.08 13.43 11.84 6.97 6.52 9.23 8.45 4.52 4.33 -4.38 -4.58 -0.20 -0.20
% of Revenue 232.18 140.27 73.78 52.98 44.48 38.83 34.42 31.22 31.53 31.78 43.03 62.41 97.54 185.84 179.16 173.44 185.78 201.48 195.41 189.68
R&D 54 59 62 65 60 55 112 170 209 247 206 164 151 139 133 126 105 85 103 121
Change (%) 9.61 5.44 5.16 -8.05 -8.75 105.37 51.31 22.69 18.50 -16.92 -20.37 -7.45 -8.05 -4.76 -5.00 -16.29 -19.46 21.08 17.41
% of Revenue 445.98 257.27 129.30 89.25 65.60 49.86 86.16 112.53 122.94 131.29 138.05 149.69 198.22 320.21 281.27 247.95 232.50 212.82 250.41 285.93
OpEx 89 106 126 147 158 168 259 349 412 475 399 324 305 287 283 280 236 191 210 229
Change (%) 18.18 19.69 16.45 7.24 6.75 53.43 34.82 18.12 15.34 -15.90 -18.91 -5.69 -6.04 -1.22 -1.23 -15.88 -18.88 9.91 9.01
% of Revenue 742.21 461.61 263.35 201.32 172.56 153.42 198.08 230.51 242.44 252.01 268.24 296.21 399.69 659.79 601.12 550.91 519.13 478.66 511.24 542.04
Operating Income -77 -83 -78 -74 -66 -59 -128 -197 -242 -286 -250 -215 -229 -243 -236 -229 -190 -151 -169 -187
Change (%) 6.99 -5.23 -5.51 -10.40 -11.60 118.17 54.17 22.57 18.41 -12.55 -14.35 6.75 6.32 -2.94 -3.03 -17.02 -20.51 11.76 10.52
% of Revenue -642.21 -361.61 -163.35 -101.32 -72.56 -53.42 -98.08 -130.51 -142.44 -152.01 -168.24 -196.21 -299.69 -559.79 -501.12 -450.91 -419.13 -378.66 -411.24 -442.04
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -2 -2 -3 -3
Change (%) 82.38 39.20 28.16 -14.17 -16.51 -17.33 -20.97 57.14 36.36 55.08 35.52 23.79 19.22 22.88 18.62 27.32 21.46 18.94 15.92
% of Revenue -0.80 -0.77 -0.51 -0.43 -0.29 -0.20 -0.14 -0.10 -0.14 -0.17 -0.33 -0.61 -1.07 -2.25 -2.55 -2.80 -4.00 -5.52 -6.38 -7.19
Net Income -67 -74 -67 -60 -53 -47 -118 -190 -219 -248 -209 -170 -197 -224 -228 -231 -194 -158 -161 -165
Change (%) 10.44 -9.95 -11.04 -10.39 -11.60 150.58 60.09 15.41 13.36 -15.74 -18.69 15.85 13.68 1.70 1.67 -15.95 -18.97 2.28 2.23
% of Revenue -559.98 -325.46 -139.70 -81.58 -58.43 -43.02 -90.71 -125.35 -128.82 -131.60 -140.34 -155.40 -257.58 -514.42 -482.51 -455.19 -428.58 -394.70 -392.33 -390.08

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista